Trial intelligence / Profile preview

Topical timolol with TCA CROSS for atrophic acne scars

IRCT20191208045657N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of timolol in atrophic acne scar, sponsored by Iran University of Medical Sciences. Started Mar 2019; status: completed.

02

Drugs

timolol
03

Conditions

atrophic acne scar

Beyond the preview

Go deeper on IRCT20191208045657N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191208045657N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call